LINCOLN.NS Net Margin
As of 2025-07-09, the Net Margin of Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is 13.2%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
LINCOLN.NS Net Margin - Historical Value
| Date | Value |
|---|---|
| 2025-03-31 | 13.2% |
| 2024-03-31 | 16.1% |
| 2023-03-31 | 14.3% |
| 2022-03-31 | 14.7% |
| 2021-03-31 | 14.7% |
| 2020-03-31 | 13.3% |
| 2019-03-31 | 13.3% |
| 2018-03-31 | 9.6% |
| 2017-03-31 | 7.7% |
| 2016-03-31 | 5.9% |
LINCOLN.NS Net Margin - Peers Comparison